Microbot Medical Inc. 8-K

What Happened

• Microbot Medical Inc. (MBOT) filed a Form 8-K (Regulation FD Disclosure) on February 5, 2026, announcing it issued a press release that it is attending the Society of Interventional Oncology (SIO) annual meeting in Savannah, GA, held February 4–8, 2026.
• The company said the timing of the conference coincides with its limited market release of the LIBERTY Endovascular Robotic System and will allow sharing of practical insights and physician experiences with LIBERTY across hospitals and procedure types. The press release is furnished as Exhibit 99.1 to the 8-K.

Key Details

• Filing date: February 5, 2026 (Form 8-K, Item 7.01, Regulation FD Disclosure).
• Event: Attendance at SIO annual meeting, Savannah, GA, February 4–8, 2026.
• Product referenced: LIBERTY Endovascular Robotic System (limited market release currently underway).
• Exhibit: Press release furnished as Exhibit 99.1 to the Form 8-K.

Why It Matters

• For investors, this disclosure highlights Microbot’s active engagement with clinicians and industry stakeholders during the limited commercial roll‑out of LIBERTY, which may provide early real‑world feedback and visibility for the product.
• Because the announcement was made under Regulation FD, material information shared at the conference is being broadly disclosed to the market via the company’s press release, helping ensure equal access to updates about commercialization progress.